Analysis of CDK5 and pTau and pCRMP2 and pDCX was performed as previously described [119 (link)] by double labeling. For this purpose, coverslips or brain sections were incubated with a rabbit polyclonal primary antibody against p-Tau or p-CRMP2 detected with FITC-conjugated secondary antibodies [1:75, Vector Laboratories] and CDK5 or pDCX detected with Tyramide Red. All sections were processed under the same standardized conditions. The immunolabeled blind-coded sections were serially imaged with a laser scanning confocal microscope [MRC-1024; Bio-Rad] and analyzed with Image J v1.43 software [NIH, Bethesda, MD], as previously described [162 (link)]. For each case, a total of three sections were analyzed and four fields were examined. Results were expressed as percent of cells displaying CDK5 in the nucleus or levels of pixel intensity.
Quantifying Neurodegeneration Biomarkers
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : University of California, San Diego
Variable analysis
- Immunohistochemistry
- Image Analysis
- Laser Scanning Confocal Microscopy
- CDK5 and pTau
- PCRMP2 and pDCX
- All sections were processed under the same standardized conditions
- The immunolabeled blind-coded sections were serially imaged with a laser scanning confocal microscope [MRC-1024; Bio-Rad] and analyzed with Image J v1.43 software [NIH, Bethesda, MD]
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!